Drug Type Small molecule drug |
Synonyms Eglumegad (INN), Eglumetad, LY-354740 |
Target |
Mechanism mGluR2 agonists(Metabotropic glutamate receptor 2 agonists), mGluR3 agonists(Metabotropic glutamate receptor 3 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC8H11NO4 |
InChIKeyVTAARTQTOOYTES-RGDLXGNYSA-N |
CAS Registry176199-48-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Panic Disorder | Phase 2 | US | 01 Nov 2005 | |
Anxiety Disorders | Preclinical | GB | 01 Feb 1998 | |
Nicotine Dependence | Preclinical | US | 01 Dec 1997 | |
Psychotic Disorders | Preclinical | US | - | |
Schizophrenia | Preclinical | US | - | |
Seizures | Preclinical | US | - | |
Seizures | Preclinical | GB | - |